IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v9y2018i1d10.1038_s41467-018-06215-z.html
   My bibliography  Save this article

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies

Author

Listed:
  • Vincent Madelain

    (Université Paris Diderot, Sorbonne Paris Cité Paris)

  • Sylvain Baize

    (Centre International de Recherche en Infectiologie)

  • Frédéric Jacquot

    (US003 Inserm)

  • Stéphanie Reynard

    (Centre International de Recherche en Infectiologie)

  • Alexandra Fizet

    (Centre International de Recherche en Infectiologie)

  • Stephane Barron

    (US003 Inserm)

  • Caroline Solas

    (Laboratoire de Pharmacocinétique et Toxicologie)

  • Bruno Lacarelle

    (Laboratoire de Pharmacocinétique et Toxicologie)

  • Caroline Carbonnelle

    (US003 Inserm)

  • France Mentré

    (Université Paris Diderot, Sorbonne Paris Cité Paris)

  • Hervé Raoul

    (US003 Inserm)

  • Xavier Lamballerie

    (UMR “Emergence des Pathologies Virales” (EPV: Aix-Marseille university - IRD 190 - Inserm 1207 - EHESP) - Institut Hospitalo-Universitaire Méditerranée Infection)

  • Jérémie Guedj

    (Université Paris Diderot, Sorbonne Paris Cité Paris)

Abstract

Despite several clinical trials implemented, no antiviral drug could demonstrate efficacy against Ebola virus. In non-human primates, early initiation of polymerase inhibitors favipiravir and remdesivir improves survival, but whether they could be effective in patients is unknown. Here we analyze the impact of antiviral therapy by using a mathematical model that integrates virological and immunological data of 44 cynomolgus macaques, left untreated or treated with favipiravir. We estimate that favipiravir has a ~50% efficacy in blocking viral production, which results in reducing virus growth and cytokine storm while IFNα reduces cell susceptibility to infection. Simulating the effect of delayed initiations of treatment, our model predicts survival rates of 60% for favipiravir and 100% for remdesivir when treatment is initiated within 3 and 4 days post infection, respectively. These results improve the understanding of Ebola immuno-pathogenesis and can help optimize antiviral evaluation in future outbreaks.

Suggested Citation

  • Vincent Madelain & Sylvain Baize & Frédéric Jacquot & Stéphanie Reynard & Alexandra Fizet & Stephane Barron & Caroline Solas & Bruno Lacarelle & Caroline Carbonnelle & France Mentré & Hervé Raoul & Xa, 2018. "Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies," Nature Communications, Nature, vol. 9(1), pages 1-11, December.
    • Handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06215-z
    DOI: 10.1038/s41467-018-06215-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-06215-z
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-018-06215-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Laura E Liao & Jonathan Carruthers & Sophie J Smither & CL4 Virology Team & Simon A Weller & Diane Williamson & Thomas R Laws & Isabel García-Dorival & Julian Hiscox & Benjamin P Holder & Catherine A , 2020. "Quantification of Ebola virus replication kinetics in vitro," PLOS Computational Biology, Public Library of Science, vol. 16(11), pages 1-15, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06215-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.